Antiviral JAK inhibitors useful in treating or preventing retroviral and other viral infections
US-10821111-B2 · Nov 3, 2020 · US
Cross-Sectional Technologies
Cross-Sectional Technologies · Cooperative Patent Classification (CPC)
General tagging of emerging or interdisciplinary technologies.
Related technology areas
Mapped technology topics for this CPC code.
| Metric | Value |
|---|---|
| CPC code | Y02A50/385 |
| Official title | — |
| Display label | Cross-Sectional Technologies (mapped technology topic) |
| Total patents | 80 |
Filing trend
Year-over-year patent counts classified under this CPC code.
Filing activity appears to be declining based on the most recent years.
| Year | Patents |
|---|---|
| 2018 | 3 |
| 2019 | 47 |
| 2020 | 30 |
Representative patents
Representative publications under this CPC code from precomputed stats, or recent filings when stats are unavailable.
Carbohydrate conjugates as delivery agents for oligonucleotides
US-10806791-B2 · Oct 20, 2020 · US
Use of trem-1 inhibitors for treatment, elimination and eradication of hiv-1 infection
US-2020316073-A1 · Oct 8, 2020 · US
Mono- or di-substituted indole derivatives as dengue viral replication inhibitors
US-10765662-B2 · Sep 8, 2020 · US
Use of TREM-1 inhibitors for treatment, elimination and eradication of HIV-1 infection
US-10765679-B2 · Sep 8, 2020 · US
Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
US-2020277291-A1 · Sep 3, 2020 · US
Compositions and methods for inhibiting expression of CD274/PD-L1 gene
US-10745704-B2 · Aug 18, 2020 · US
Antiviral jak inhibitors useful in treating or preventing retroviral and other viral infections
US-2020206229-A1 · Jul 2, 2020 · US
1,2,4-Oxadiazole Derivatives as Immunomodulators
US-2020199086-A1 · Jun 25, 2020 · US
Compositions and methods for the prevention and treatment of mast cell-induced vascular leakage
US-10668059-B2 · Jun 2, 2020 · US
Antiviral agent comprising RNA oligonucleotide
US-10519452-B2 · Dec 31, 2019 · US
Immunosuppressive agents and their use in therapy
US-10517923-B2 · Dec 31, 2019 · US
Dosing regiments of celgosivir for the treatment of dengue
US-10517854-B2 · Dec 31, 2019 · US
Methods and compositions for inhibition of polymerase
US-2019374544-A1 · Dec 12, 2019 · US
3-alkyl pyridinium compound from red sea sponge with potent antiviral activity
US-2019358210-A1 · Nov 28, 2019 · US
Treatment method by combined use of MDM2 inhibitor and BTK inhibitor
US-10485794-B2 · Nov 26, 2019 · US
Cationic polyamines for treatment of viruses
US-10485824-B2 · Nov 26, 2019 · US
Compositions and methods useful for the prevention of malaria and dengue virus transmission
US-2019350207-A1 · Nov 21, 2019 · US
Macrocyclic inhibitors of flaviviridae viruses
US-10472392-B2 · Nov 12, 2019 · US
Flavivirus protease inhibitors
US-10471082-B2 · Nov 12, 2019 · US
Frequently asked questions
Answers are generated from the same data shown on this page.
- What is CPC Y02A50/385?
- CPC Y02A50/385 is the Cooperative Patent Classification code for “Cross-Sectional Technologies.”
- How many patents are filed under CPC Y02A50/385 (Cross-Sectional Technologies)?
- Our database includes 80 publications tagged with this CPC code.
- Is patent activity under CPC Y02A50/385 growing?
- Publication counts under this code: 47 in 2019 vs 30 in 2020 (latest complete years).